(New York)

Passive funds have seen a meteoric rise since the Financial Crisis, with AUM soaring by trillions. But within that huge growth, what have been the best returning passive funds? Financial Planning produced a slide show presenting the twenty best. The top performing funds list is dominated by the big three providers—BlackRock, Vanguard, and State Street, who also have 82% of all passive AUM. The top five returning funds are the SPDR S&P Biotech (XBI), Invesco Dynamic Pharmaceuticals ETF (PJP), the First Trust NYSE Arca Biotech ETF (FBT), the Invesco Nasdaq Internet ETF (PNQI), and the First Trust Dow Jones Internet ETF (FDN).

FINSUM: Looks like biotech and tech stocks had a great decade (nor surprise there). The rest of the top twenty is similarly dominated by tech and healthcare, but consumer stocks, defense, and semiconductors also show up.

(New York)

All precious metals have been in a tough bear market for several years. Rising rates and a strengthening Dollar have effectively blocked any recovery. The question then is when do they get cheap enough that it is a no-brainer buy? Perhaps right now. Gold’s ratio to silver just hit its highest point since 2008, making silver a buy. Silver has fallen 16% this year, almost double gold’s fall, making it the cheapest in a decade. Gold currently trades at over 80x silver, compared to a ratio of just above 30x in 2011.

FINSUM: The big question here is a catalyst. What would spark a rally? We are not specialists in precious metals, so we won’t comment, but we are sure it will take something significant to break a 6-year slump like this one.

(New York)

If you are an investor looking for safe yields, look no further than this handful of high-yielding stocks. All three stocks presented here have yields over 5%. That level may prove a key defensive barrier, as shares with yields that lofty are less likely to be affected by rate rises. The three stocks are REIT EPR Properties (6.2% yield), healthcare company Welltower (5.2%), and property giant Brookfield Property Partners (6%+ yield).

FINSUM: Brookfield, in particular, seems like a good buy, as its business looks very strong and it is trading at a big discount versus the value of its real estate holdings.

(Washington)

Investors in tech have reason to worry. Not only is Trump saying that they should possibly be subjected to anti-trust regulation, but the tech sector is heading to Washington today to meet with the Senate. Top executives at Facebook, Google, and Twitter, are set to face questions and scrutiny about their practices, including on trust concerns, political content, and consumer privacy. The tide of public opinion has turned against tech over the last year, and congress has followed suit, with Senate GOP leader Orrin Hatch calling Google’s anti-trust behavior “disquieting” despite the fact that he used to staunchly defend the sector.

FINSUM: The big problem for tech is that a regulatory crackdown now seems to have bipartisan support. We think there will be some regulations imposed on tech, but the depth of the forthcoming rules will be the deciding factor. In other words, will it be something along the lines of GDPR (relatively light) or more like Glass-Steagal?

(Washington)

By far the biggest focus of the recent tax package has been its limiting of SALT deductions to just $10,000. The current implementation of the rule was considered phase one by Republicans, with phase two—making the changes permanent—supposed to happen this fall. However, given how tight the congressional races are, including in high tax states like New York, New Jersey, Minnesota, and Illinois, many Republicans are now considering delaying the vote so that sitting representatives don’t have to take a stand on the package.

FINSUM: The SALT limits are wildly unpopular in many locations, and the Republicans are rightfully worried that pushing for making them permanent could cost them some seats. Will this eventually lead to the repeal of the rule?